COMMUNIQUÉS West-GlobeNewswire

Cocrystal Pharma Announces Clinical Trial Agreement for Investigator-Initiated Phase 2a Study in Hong Kong of CC-31244 for Ultra-Short Treatment of Hepatitis C Virus
08/10/2018
- Humanity & Health Research Centre to conduct Phase 2a study evaluating CC-31244 for the treatment of hepatitis C - Asia market represents one of the largest hepatitis C virus carrier populations in the world [...]
Public Company Becomes Newest Entrant In Alarm Industry; NuLife Expands from Life Sciences to Life Safety
08/10/2018
NEWPORT BEACH, Calif., Oct. 08, 2018 (GLOBE NEWSWIRE) -- NuLife Sciences, Inc . (OTCQB: “NULF”) announced today that it has successfully closed its previously announced merger with two Louisiana-based electronic [...]
Menlo Therapeutics Announces Results from a Phase 2 Clinical Trial of Serlopitant for the Treatment of Refractory Chronic Cough
08/10/2018
Serlopitant fails to demonstrate efficacy relative to placebo on primary and secondary endpoints REDWOOD CITY, Calif., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO) a late-stage [...]
Novo Nordisk A/S - Share repurchase programme
08/10/2018
Bagsværd, Denmark, 8 October 2018 - On 10 August 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 [...]
Pacific Biosciences Releases Highest-Quality, Most Contiguous Individual Human Genome Assembly to Date
08/10/2018
Diploid Assembly of a Puerto Rican Female Adds a Rich Resource to Population-Specific Reference Genomes MENLO PARK, Calif., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), the [...]
Spark Therapeutics Announces New Preclinical Data for Pompe Disease Gene Therapy Candidate
08/10/2018
Data from IND-enabling studies in three species support moving SPK-3006 into the clinic in 2019 PHILADELPHIA, Oct. 08, 2018 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated, commercial gene [...]
FSD Pharma: Strategic Investments & Clean Balance Sheet -- CFN Media
08/10/2018
SEATTLE, Oct. 08, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
TG Therapeutics, Inc. Highlights Schedule of Events at the Upcoming 34th Congress of ECTRIMS
08/10/2018
Final ublituximab phase 2 Multiple Sclerosis data to be featured in an oral presentation, Thursday, October 11, 2018, 16:51-17:03 CEST ECTRIMS data review conference call to be held Thursday, October 11, 2018, 19:30 [...]
Assertio Therapeutics to Report Third-Quarter 2018 Financial Results After The Close of Markets on Thursday, November 8, 2018
08/10/2018
LAKE FOREST, Ill., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ:ASRT) today announced that it will release third-quarter 2018 financial results on Thursday, November 8, 2018, after the close of [...]
PhaseBio Launches Roadshow for Initial Public Offering
08/10/2018
MALVERN, Pa. and SAN DIEGO, Oct. 08, 2018 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc. (“PhaseBio”), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies [...]
Amicus Therapeutics Enters Research and Development Collaboration with University of Pennsylvania to Develop AAV Gene Therapies
08/10/2018
Collaboration Focuses on Four Genetic Disorders: Pompe, Fabry, CDKL5 and One Additional Undisclosed Rare Metabolic Disorder Combines Amicus Expertise in Protein Engineering with Penn’s AAV Vector Technology, [...]
Cancer Genetics and Cellaria Partner on Precision Medicine Tools
08/10/2018
Collaboration focused on developing pharmacology models to support biopharma R&D RUTHERFORD, N.J., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics (Nasdaq: CGIX), a leader in enabling precision medicine for immuno [...]
Recro Pharma Announces PDUFA Date for IV Meloxicam
08/10/2018
PDUFA Date Set for March 24, 2019 MALVERN, Pa., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and [...]
Inspire Medical Systems, Inc. Announces First Implant of New Sensing Lead in Europe
08/10/2018
MINNEAPOLIS, Oct. 08, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
Akcea Announces Changes to Board of Directors
08/10/2018
Dr. Damien McDevitt replaces Dr. Stanley Crooke on Akcea Board of Directors The change enhances focus on global approval and commercialization of TEGSEDI™ (inotersen) BOSTON, Oct. 08, 2018 (GLOBE NEWSWIRE) -- Akcea [...]
Transactions under Novozymes’ stock buyback program
08/10/2018
Please read the full announcement in the attached PDF Attachment 2018_57_Stock_Buybackprogram_EN
Tetraphase Pharmaceuticals Announces Presentation of Positive Data from Phase 3 Trials of XERAVA™ (eravacycline) and Multiple-Ascending Dose Trial of TP-6076 at IDWeek 2018
08/10/2018
XERAVA Demonstrated Efficacy in Treating Secondary Bacteremia in Patients with Complicated Intra-Abdominal Infections in Post-Hoc Analysis of Phase 3 Clinical Trials TP-6076 Demonstrated Favorable Pharmacokinetic and [...]
OraSure Technologies Earnings Conference Call Invitation
08/10/2018
2018 Third Quarter Earnings Conference Call Wednesday, November 7, 2018, 5:00 p.m. ET BETHLEHEM, Pa., Oct. 08, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings [...]
Arrayit Corporation Aces Three Consecutive Rounds of Proficiency Testing with the College of American Pathologists
08/10/2018
Sunnyvale, Oct. 08, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, reports that its clinical team aced three consecutive rounds of blinded-specimen [...]

Pages